Dangerous Drugs
Most Dangerous Defective Products
Every year, defective products cause thousands of consumer injuries and deaths. While many defective products have the potential to inflict life-changing damage, certain items have historically resulted in a greater number of serious incidents and recalls than others. From exploding...
Read More
Can I File a Medical Malpractice Lawsuit After a Drug Recall?
If you are prescribed a dangerous or defective drug, you may have grounds for one or two different types of civil lawsuits. You may be able to file a medical malpractice lawsuit if the physician who prescribed the drug knew...
Read More
NuvaRing manufacturer fought for no risk warning on labels
In 2002, the Dutch drug manufacturer, Organon, released NuvaRing, one of the most popular contraceptive drugs in history. The multi-billion dollar product, NuvaRing, was marketed as the first hormonal contraceptive ring in the entire world. Banking on convenience, it was...
Read More
Amylin Pharmaceutical’s Byetta among worst of diabetes drugs to be called into court
It was announced only a few weeks ago that people who have filed claims against Bristol-Myers Squibb and its subsidiary, Amylin Pharmaceuticals, in regards to the drug Byetta, will be moving forward with their cases in due time.Recent developments over...
Read More
Januvia lawsuits hit U.S. District Court, many more likely to follow
There are now more than 150 lawsuits involving Januvia and other kinds of Type 2 diabetes drugs, according to recent court filings. Federal proceedings have begun in a United States District Court in the Southern District of California. Every single...
Read More
Johnson & Johnson, Janssen Pharmaceuticals pay out $15 million over past two months in Topamax cases
On November 18, a Pennsylvania state jury awarded $11 million to the mother of a little boy who was born with a cleft palate as a result of her prescription to the dangerous drug, Topamax. Johnson & Johnson's subsidiary, Janssen...
Read More
Use of drugs like Lipitor could reach 70 million with new guidelines
New U.S. guidelines for treating people with high cholesterol could literally double the number of people on drugs such as Lipitor. Many are surprised at this news because of the legal controversies surrounding Lipitor and its propensity to develop Type...
Read More
Bone fractures and breaks added to the lengthening list of Actos side effects
Serious health issues regarding Actos and its relationship to bone fractures have been capturing the attention of health professionals and Type 2 diabetes patients across the country and around the globe.For more than fourteen years, millions upon millions of Type...
Read More
Johnson & Johnson pays $2.2 billion in Risperdal settlements
Last week, the Department of Justice and the FDA announced that Janssen Pharmaceuticals has pled guilty to misleading buyers of the drug Risperdal and selling it under fabricated pretenses. Johnson & Johnson and its subsidiary, Janssen, will pay a total...
Read More